CDEK
← All organizations

Nuvisan Pharma Services

For profitWebsite ↗

Also known as: FOCUS CDD GmbH | FOCUS Clinical Drug Development | FOCUS clinical Drug Development GmbH | FOCUS Clinical Drug Development GmbH | FOCUS Clinical Drug Development GmbH Stresemannallee 6 41460 Neuss Germany | FOCUS GmbH | Nuvisan | Nuvisan, Germany | Nuvisan GmbH | Nuvisan GmbH, 89231 Neu-Ulm | Nuvisan Pharma Services GmbH & Co. KG

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2003

Last known activity

Dec 1, 2025

Timeline

1970s

  1. Jun 1, 1979

    Nuvisan Pharma Services— Founded

2010s

  1. Jun 1, 2011

    Essex Pharma— Acquired

Drugs by trial phase (39 distinct, 33 trials)

Phase 4 (1 own, 2 via acquisition)

Phase 3 (0 own, 4 via acquisition)

Phase 2 (3 own, 2 via acquisition)

Other trials (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (26)

  • NCT07312643CollaboratorPhase 1Dec 1, 2025
  • NCT06689527OfficialPhase 1Aug 13, 2024
  • NCT06649409OfficialPhase 1Jun 17, 2024
  • NCT05343819Overall official - principal investigatorPhase 1Apr 12, 2022
  • NCT05087069CollaboratorPhase 1Oct 8, 2021
  • NCT05018403Overall official - principal investigatorPhase 1Aug 3, 2021
  • NCT04959344Overall official - principal investigatorPhase 1/Phase 2Jul 5, 2021
  • NCT04636983Overall official - principal investigatorPhase 1Nov 9, 2020
  • NCT03955380CollaboratorPhase 1Dec 12, 2018
  • NCT03126578Overall official - principal investigatorPhase 1May 31, 2017
  • NCT03055936Overall official - principal investigatorPhase 1Feb 21, 2017
  • NCT03037788Overall official - principal investigatorPhase 1Nov 1, 2016
  • NCT03037788CollaboratorPhase 1Nov 1, 2016
  • NCT02912377Overall official - principal investigatorPhase 1Sep 1, 2016
  • NCT02629562Overall official - principal investigatorPhase 1Nov 1, 2015

Details

Founded
ULm, DE Jun 1, 1979
Last known activity
Dec 1, 2025

Notes

CRO